Cvs Health Corp (CVS) Shareholder Matrix Asset Advisors INC Decreased Stake by $7.90 Million

May 3, 2018 - By Matthew Medley

CVS Health Corporation (NYSE:CVS) Corporate LogoDuring Q4 2017 the big money sentiment decreased to 0.72. That’s change of 0.16, from 2017Q3’s 0.88. 115 investors sold all, 600 reduced holdings as CVS ratio worsened. 380 grew stakes while 134 funds took stakes. Funds hold 815.59 million shares thus 1.76% more from 2017Q3’s 801.45 million shares. World Asset Mgmt reported 92,346 shs or 0.22% of all its holdings. At Savings Bank has 9,119 shs for 0.07% of their capital. State Bank Of Montreal Can owns 0.37% invested in CVS Health Corporation (NYSE:CVS) for 5.81M shs. Dubuque Bankshares Tru Co invested in 74,417 shs or 0.82% of the stock. Louisiana State Employees Retirement Systems accumulated 0.2% or 61,300 shs. C Ww Wide Grp Holdings A S has 0.02% invested in CVS Health Corporation (NYSE:CVS). Cipher Capital LP has 19,918 shs. Verition Fund Management Ltd has invested 0.16% in CVS Health Corporation (NYSE:CVS). South State reported 67,125 shs stake. Compass Capital Mngmt Inc stated it has 3.73% of its capital in CVS Health Corporation (NYSE:CVS). Peak6 Invs Lp has 113,404 shs for 0.04% of their capital. Cibc Ww, a Ontario – Canada-based fund reported 128,225 shs. Hutchinson Capital Mgmt Ca reported 166,346 shs. First Midwest Natl Bank Division stated it has 11,944 shs. Vanguard Grp Inc invested 0.25% in CVS Health Corporation (NYSE:CVS).

CVS registered $1.42 million net activity with 0 insider buys and 1 insider sale since February 16, 2018.

According to 2017Q4 Securities and Exchange filling the Matrix Asset Advisors Inc reduced its holdings in Cvs Health Corp (CVS) by 41.47%. The company’s stock declined 17.45% with the market as Matrix Asset Advisors Inc sold 109,689 shares. At the end of 2017Q4, the 154,821 shares of the medical and nursing services company held by the institutional investor were valued at $11.23 million, down from 264,510 at the end of the previous reported quarter. $67.03B is the MC of Cvs Health Corp. Ticker’s shares touched $65.94 during the last trading session after 3.03% change.CVS Health Corporation has 14.32 million shares volume, 63.01% up from normal. CVS is downtrending and has moved 22.81% since May 3, 2017. The stock underperformed the S&P500 by 34.36%.

For a total of shares it increased its holding in by shares in the quarter, and has risen its stake in .

CVS Health Corporation (NYSE:CVS) Ratings Coverage

Total analysts of 15 have positions in CVS Health (NYSE:CVS) as follows: 11 rated it a “Buy”, 0 with “Sell” and 4 with “Hold”. The positive are 73%. The firm has $95.0 highest while $73 is the lowest PT. The average target $84.33 is 27.89% above the last ($65.94) price. Since November 7, 2017 according to StockzIntelligence Inc CVS Health has 30 analyst reports. On Friday, January 5 the rating was upgraded by Morgan Stanley to “Overweight”. On Monday, January 8 the company was maintained by Leerink Swann. On Thursday, February 8 the stock of CVS Health Corporation (NYSE:CVS) earned “Buy” rating by RBC Capital Markets. On Wednesday, May 2 the stock has “Buy” rating by Oppenheimer. In Tuesday, April 10 report Leerink Swann maintained the stock with “Buy” rating. In Tuesday, January 2 report Needham maintained the stock with “Buy” rating. On Monday, November 13 the rating was maintained by Citigroup with “Neutral”. On Tuesday, December 26 Tigress Financial maintained the shares of CVS in report with “Buy” rating. On Monday, December 4 the rating was maintained by RBC Capital Markets with “Buy”. On Wednesday, January 24 the firm has “Buy” rating given by Mizuho.

CVS Health Corporation (NYSE:CVS) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.